16:40 EDT Spero Therapeutics files $300M mixed securities shelf
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See Insiders’ Hot Stocks on TipRanks >>
Read More on SPRO:
- Spero Therapeutics reports Q4 EPS (96c), consensus (10c)
- Spero Therapeutics Announces Fourth Quarter and Full Year 2023 Operating Results and Provides a Business Update
- Is SPRO a Buy, Before Earnings?
- Spero Therapeutics to Provide Business Update and Report Fourth Quarter and Full Year 2023 Financial Results on Wednesday, March 13, 2024
- Cantor Fitzgerald biotech/biopharma analysts analyst/industry conference call